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The MarR family of transcriptional regulators comprises a subset of winged helix DNA-binding proteins
and includes numerous members that function in environmental surveillance of aromatic compounds. We describe the characterization of HucR, a novel MarR homolog from Deinococcus radiodurans that demonstrates
phenolic sensing capabilities. HucR binds as a homodimer to a single site within its promoter/operator
region with Kd ⴝ 0.29 ⴞ 0.02 nM. The HucR binding site
contains a pseudopalindromic sequence, composed of
8-bp half-sites separated by 2 bp. The location of the
HucR binding site in the intergenic region between
hucR and a putative uricase suggests a mechanism of
simultaneous co-repression of these two genes. The substrate of uricase, uric acid, is an efficient antagonist of
DNA binding, reducing HucR-DNA complex formation
to 50% at 0.26 mM ligand, compared with 5.2 and 46 mM
for the aromatic compounds salicylate and acetylsalicylate, respectively. Enhanced levels in vivo of hucR and
uricase transcript and increased uricase activity under
conditions of excess uric acid further indicate a novel
regulatory mechanism of aromatic catabolism in D. radiodurans. Since uric acid is a scavenger of reactive
oxygen species, we hypothesize that HucR is a participant in the intrinsic resistance of D. radiodurans to high
levels of oxidative stress.

Members of the MarR family of winged helix transcriptional
regulators control a variety of biological functions in bacteria
and Archaea (1). Several transcriptional activators have been
identified in this family, but the majority of MarR homologs are
transcriptional repressors (2, 3). A number of bacterial MarR
proteins regulate environmental stress responses and the expression of pathogenic factors. For example, MexR represses
the MexAB-OprM operon of Pseudomonas aeruginosa, an
operon that encodes a tripartite efflux system responsible for
this organism’s intrinsic resistance to multiple antibiotics (4,
5). PecS from Erwinia chrysanthemi regulates pectinase and
cellulase production, the main virulence determinants of this
plant pathogen, and the synthesis of indigoidine, an apparent
scavenger of reactive oxygen species (6, 7). Other members of
the MarR family regulate the catabolism of aromatic compounds, such as HpaR, which mediates the catabolism of 4-hydroxyphenylacetic acid in Escherichia coli, and HpcR, which
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regulates homoprotocatechuate catabolism (8, 9). Autoregulation is a characteristic of a number of MarR proteins, including
the operon repressors EmrR and MarR, and several homologs
that are not encoded in the context of a contiguous operon, such
as MexR and HpaR (8, 10 –12).
Phenolic ligands have been shown to regulate gene expression by negatively affecting interactions of MarR homologs
with their cognate promoter/operator regions. Repressor activity of EmrR on the multidrug resistance operon, emrRAB in
E. coli, is antagonized in vitro by sodium salicylate and a
variety of structurally unrelated phenolic drugs that are putative ligands of the multidrug pump encoded by this operon (10,
13). The affinity of CinR, a repressor of a cinnamoyl ester
hydrolase from Butyrivibrio fibrisolvens E14, for its binding
region is reduced in vitro by cinnamic acid derivatives (14).
HpcR repression of homoprotocatechuate metabolic genes and
HpaR repression of the hpa-meta operon are relieved by the
respective aromatic substrates of these catabolic pathways
(8, 9). Similarly, the regulators of benzoic acid and 3-chlorobenzoate catabolism, BadR and CbaR, respectively, respond to
the aromatic substrates of their pathways (2, 15).
The prototypical member of this protein family, MarR from
E. coli, negatively regulates the marRAB operon, the expression of which confers an intrinsic phenotypic resistance to
structurally diverse antibiotics, organic solvents, oxidative
stress agents, and household disinfectants (11, 16, 17). MarR
binds as a homodimer to two sites on the operator/promoter
(marO) of this operon with an apparent Kd of ⬃1 nM, with site
I partially overlapping the ⫺35 and ⫺10 regions of the promoter and site II overlapping the putative ribosome binding
site (18). A range of phenolic compounds induce marRAB transcription in vivo, including sodium salicylate, cinnamate, 2,4dinitrophenol, acetaminophen, sodium benzoate, tetracycline,
and chloramphenicol, and a subset of these, as well as plumbagin and menadione, antagonize DNA binding activity of
MarR in vitro (16, 19 –21). Sodium salicylate has been shown to
bind MarR with an apparent Kd value of 0.5–1 mM (18). The
2.3-Å crystal structure of MarR bound to sodium salicylate
revealed two binding sites per monomer for this inducer, with
each site flanking the putative recognition helix of the DNA
binding motif (22).
The heterotrophic, mesophilic bacterium Deinococcus radiodurans is best known for its resistance to high levels of ionizing
and UV radiation, bulky chemical adducts, and other agents
that damage DNA (23–25). Genomic analysis revealed that
D. radiodurans also encodes orthologs of nearly every known
bacterial stress response protein, suggesting mechanisms of
resistance to osmotic, temperature, pH, starvation, toxin,
phage, dessication, antibiotic, and oxidative stresses (25, 26).
The presence of two genes encoding MarR homologs, dr1159
and dra0248 (TIGR gene annotation), within the genome sug-
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gested an uncharacterized stress response regulatory system or
a novel mode of metabolic regulation in D. radiodurans.
In this paper, we report the cloning of dr1159 from D. radiodurans and the subsequent purification of HucR (hypothetical
uricase regulator) belonging to the MarR family of transcriptional regulators. Characterization of this novel protein reveals
that it binds as a dimer with very high affinity to a promoter
region shared between hucR and a neighboring uricase.
Through electrophoretic mobility shift assays (EMSAs),1 we
demonstrate that this affinity is antagonized by specific phenolic compounds, notably uric acid. These results, in conjunction with in vivo analyses, indicate a novel catabolic regulatory
system in D. radiodurans.
EXPERIMENTAL PROCEDURES

Cloning, Overexpression, and Purification of HucR—D. radiodurans
R1 was kindly provided by J. Battista, and genomic DNA was isolated
as described (27). PCR amplification of the hucR ORF (dr1159) from the
genome was achieved using primers HucR-fwd (5⬘-GCT CGT GTT CAT
ATG TCA GCC CGC-3⬘), which introduced an NdeI site (boldface type)
overlapping the first codon (underlined), and HucR-rev (5⬘-CCT TTC
CGG AAT TCC GGG AAT C-3⬘), which introduced an EcoRI site (boldface type) downstream of the hucR stop codon. The resulting 589-bp
PCR product was cloned into pET-5a, generating pSPW1. Plasmid
pSPW1 was transformed into E. coli TOP10 (Invitrogen). Fidelity of the
construct was verified by DNA sequencing. Plasmid pSPW1 was subsequently transformed into E. coli BL21(DE3)pLysS. Cultures were
grown in LB containing 100 g/ml ampicillin at 37 °C to A600 ⫽ 0.5, and
HucR overexpression was induced with 0.2 mM isopropyl-1-thio-␤-Dgalactopyranoside for 1 h. Cells were pelleted at 4 °C and stored at
⫺80 °C. All subsequent steps were carried out at 0 – 4 °C. Cells were
resuspended in lysis buffer (50 mM Tris-HCl (pH 8), 25 mM NaCl, 5%
glycerol (v/v), 5 mM Na2EDTA, 0.15 mM phenylmethylsulfonyl fluoride,
10 mM 2-mercaptoethanol) and incubated with 200 g/ml lysozyme for
1 h. Triton X-100 and NaCl were added to final concentrations of 0.05%
(v/v) and 0.5 M, respectively. DNA was removed from the lysate by the
slow addition of Polymin P to a final concentration of 0.5% (v/v) followed
by centrifugation at 11,000 ⫻ g for 20 min. The supernatant was
dialyzed overnight against 30 volumes of HA buffer (20 mM Tris-HCl
(pH 8.7), 50 mM KCl, 4.8% glycerol (v/v), 1 mM Na2EDTA, 4.3 mM
2-mercaptoethanol, 0.2 mM phenylmethylsulfonyl fluoride) and centrifuged at 11,000 ⫻ g for 20 min. The supernatant was loaded onto
CM-Sepharose and DEAE-Sepharose columns, linked in tandem and
equilibrated with HA buffer, pH 8.7. The HucR-containing flow-through
and wash fractions were combined and concentrated using a Centriprep
centrifugal filter device (Millipore Corp.). The concentrated retentate
was dialyzed for 3 h against 60 volumes of HAP buffer (20 mM potassium phosphate (pH 7), 50 mM KCl, 4.8% glycerol (v/v), 1 mM Na2EDTA,
4.3 mM 2-mercaptoethanol, 0.2 mM phenylmethylsulfonyl fluoride) and
loaded onto a hydroxyapatite column equilibrated with HAP buffer, pH
7. The wash fractions containing HucR were loaded onto a heparin
column equilibrated with HAP buffer, pH 7, and HucR was eluted with
a linear gradient of 50 mM to 1 M KCl in HAP buffer, pH 7. Peak
fractions were pooled and concentrated, and the glycerol concentration
was increased to 20%. The purity of HucR was established by SDSPAGE and Coomassie staining. HucR concentration was ascertained
spectrophotometrically using ⑀280 ⫽ 13,512 M⫺1 cm⫺1 and verified by
SDS-PAGE using bovine serum albumin (BSA) as a standard.
Circular Dichroism Spectroscopy—CD spectroscopy was performed
on an Aviv 202 CD spectrophotometer. HucR was diluted to 0.2 mg/ml
in CD buffer A (20 mM potassium phosphate (pH 7), 34 M EDTA, 0.8%
glycerol, 13 mM KCl). Ellipticity measurements were performed in
triplicate at 25 °C using a quartz cuvette with a 0.1-cm path length.
Measurements were made at 1-nm steps over the wavelength range
from 250 to 190 nm and were corrected for buffer contributions to the
signal. HucR secondary structure composition was calculated using the
secondary structure algorithm CDSSTR and protein reference set 7
provided by the authors (28 –32). The goodness of fit was determined
from the NRMSD value of 0.013.
For measurement of thermal stability, HucR was diluted to 0.05
mg/ml in CD buffer B (20 mM potassium phosphate (pH 7), 8 M EDTA,
1
The abbreviations used are: EMSA, electrophoretic mobility shift
assay; BSA, bovine serum albumin; MPE, methidiumpropyl-EDTA;
ORF, open reading frame.
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0.2% glycerol, 3 mM KCl), and measurements were made using a quartz
cuvette with a 1-cm path length. Ellipticity readings from 230 to 200 nm
(1-nm steps) were taken over the temperature range 19 –70 °C, with
steps of 3 °C (19 –37 and 61–70 °C) or 1.5 °C (37– 61 °C). Each sample
also underwent a reverse scan from 67 to 19 °C. 3 min was allowed for
thermal equilibration after each step. Wavelength scans from 240 to
200 nm were performed at 19 and 70 °C to verify the native and
denatured states of HucR, respectively. CD measurements of HucR
melting were performed in triplicate and corrected for buffer contributions to the signal. Calculation of the Tm of HucR was made based on
ellipticity measurements from 224 to 220 nm. Temperature-dependent
ellipticity values were plotted at each wavelength and fit to a two-state
model for protein unfolding (33). The Tm of HucR is reported as the
average ⫾ S.D.
HucR-hucO Stoichiometry and Affinity Determination—Primers
were designed according to the D. radiodurans genome to amplify a
241-bp segment that included the entire intergenic region between
hucR and dr1160 and extended 61 and 79 bp into the coding region of
each gene, respectively. The resulting PCR product, hucO, was gelpurified and 32P-labeled with T4-polynucleotide kinase.
For binding assays under stoichiometric conditions, 0.1 M 32P-labeled hucO was titrated with HucR up to 0.35 M, in a total reaction
volume of 10 l in Binding Buffer (20 mM Tris-HCl (pH 8), 0.1 mM
Na2EDTA, 0.075% BRIJ58, 50 mM NaCl, 5 mM MgCl2, 50 g/ml BSA,
and 4% (v/v) glycerol). Protein-DNA complexes were equilibrated at
22 °C for 1 h. A nondenaturing 6.5% polyacrylamide gel was prerun for
30 min in 0.5⫻ TBE buffer (45 mM Tris borate (pH 8.3), 1.25 mM
Na2EDTA), and samples were loaded with the power on. After 1.25 h of
electrophoresis, the gels were dried, and protein-DNA interactions were
analyzed by phosphorimaging using a STORM 840 PhosphorImager
and ImageQuant 1.1 software. Fractional complex formation was plotted against [HucR]/[hucO] and fit to a spline curve. Tangents were
generated from data points in the upward slope and the plateau, and
the stoichiometry of HucR-hucO complex formation extrapolated algebraically. Experiments were performed in duplicate.
EMSAs for Kd determination were performed as described above,
except that binding reactions involved 0.1 nM 32P-labeled hucO titrated
with HucR up to 30 nM. The binding isotherm for Kd determination was
generated by nonlinear fit of three data sets to the binding equation:
normalized fractional saturation of hucO ⫽ (n(P)/Kd)/(1 ⫹ (P/Kd)),
where n represents the number of HucR binding sites, P is free protein
concentration, and Kd is the observed equilibrium dissociation constant.
The Kd value is reported as the mean ⫾ S.D. In the competition assay,
binding conditions were as described above, involving 0.1 nM 32P-labeled hucO titrated with up to 10 nM unlabeled hucO or pGEM5. HucR
was added last to the binding reactions, at a final concentration of 1 nM.
Methidiumpropyl-EDTA (MPE)-Fe(II) and DNase I Footprinting—
Complementary 77-mer oligonucleotides were gel-purified, and the
“top” strand was 5⬘-end-32P-labeled with T4-polynucleotide kinase. Annealing of the oligonucleotides was accomplished by slow cooling from
90 to 16 °C. Binding reactions were in a total volume of 10 l and
included 500 fmol of DNA in modified Binding Buffer with 0.06%
BRIJ58, 20 g/ml BSA, and 1.5% glycerol. Protein-DNA complexes were
equilibrated for 1 h at 22 °C. For MPE-Fe(II) footprinting, 1 l of 10 mM
sodium ascorbate was added, followed by 2 l of MPE mix (25 M MPE,
25 M Fe(NH4)2(SO4)2), and digestion was allowed to proceed for 2 min
at room temperature. DNase I footprinting samples were incubated
with 10⫺3 to 10⫺2 units of DNase I (Epicentre) for 30 s at room temperature. Digestion was terminated by phenol-chloroform extraction,
and samples were ethanol-precipitated. A/G chemical sequencing ladders were generated according to Sambrook et al. (34). DNA fragments
were separated on a 12% polyacrylamide sequencing gel. Density profiles were obtained by phosphorimaging.
Ligand Binding Assays—A 180-bp sequence spanning bp ⫺158 to
⫹22 relative to the hucR translational start site (bp ⫺76 to ⫹104
relative to the predicted dr1160 transcriptional start site) was amplified, gel-purified, and 32P-labeled with T4-polynucleotide kinase. For
each ligand assayed, binding conditions were established to buffer pH
effects from the compound. Binding reactions were assembled in Binding Buffer with 0.1 nM DNA, 0.75 nM HucR, and up to 25 mM sodium
salicylate. EMSAs were also performed without BSA in the Binding
Buffer with no detectable effect. For acetylsalicylate assays, acetylsalicylate was dissolved in ethanol, and binding reactions were assembled
in modified Binding Buffer with 400 mM Tris-HCl (pH 8) and 20%
ethanol with up to a 25 mM concentration of the compound. Uric acid
was dissolved in 0.35 M NaOH to a concentration of 125 mM. Binding
reactions were assembled in modified Binding Buffer with 500 mM
Tris-HCl (pH 8), 0.05% BRIJ58, 7.5 g/ml BSA, and 0.6% glycerol with
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FIG. 1. The genetic organization of dr1159 and adjacent ORFs. The relative orientations of the ORFs are represented by open arrows. HucR
is encoded by dr1159, dr1160 encodes a hypothetical uricase, and dr1161 encodes a transthyretin-like protein. An intergenic region of 101 bp
separating hucR and dr1160/dr1161 contains putative 70 ⫺10 and ⫺35 promoter elements for each gene, designated by bars above (dr1160/
dr1161) or below (dr1159) the sequence. Predicted transcription and translation start sites are identified by asterisks and arrows, respectively. The
shaded box marks the HucR binding site. Each half-site of the pseudopalindromic sequence within the binding site is identified in boldface type.
up to 20 mM uric acid. Reactions were equilibrated for 1 h at 22 °C, and
protein-DNA complexes were analyzed by EMSA as described above.
All experiments were carried out in triplicate. Data were fit to a single
exponential equation: normalized fractional complex formation ⫽ e⫺kL,
where k is the exponential decay constant, and L is the ligand
concentration.
RNA Dot Blot Hybridization—10 l of an overnight culture of D.
radiodurans was added to 5 ml of TGY broth (0.5% tryptone, 0.3% yeast
extract, 0.1% glucose) or 5 ml of TGY broth supplemented with 10 mM
uric acid. Before inoculation, the pH of broths containing uric acid was
adjusted to that of TGY broth. Cultures were grown at 30 °C to A600 ⫽
0.45, and cells were harvested by centrifugation at 4 °C at 12,000 ⫻ g
for 10 min and stored at ⫺80 °C. Pellets were resuspended in 3 ml of
95% ethanol and held at 4 °C for 10 min and harvested by centrifugation at 4 °C at 12,000 ⫻ g for 10 min. Total RNA was prepared as
described (35). DNA contamination was removed by digestion with 1 g
of RNase-free DNase I (Epicentre) at 37 °C for 1 h.
RNA dot blots were performed essentially as described (35). For each
RNA sample, 15 g was adhered to a (⫹)-charged nylon membrane
using a Bio-Dot microfiltration apparatus (Bio-Rad) and cross-linked
using a Stratalinker UV cross-linker (Stratagene) at 120,000 J/cm2 for
50 s. Oligonucleotide probes complementary to the dr1160 transcript
(⫹30 to ⫹49 relative to the predicted start site of translation) and to the
hucR transcript (⫹21 to ⫹40 relative to the start site of translation)
were used. Since groESL (dr0606 – 0607) expression in D. radiodurans
has been shown to be constitutively expressed under different growth
conditions, a probe was designed complementary to residues ⫹310 to
⫹330 of groES to serve as a normalizing factor for RNA samples (36).
The probes were 32P-labeled with T4-polynucleotide kinase, separately
hybridized to the cross-linked membranes overnight and washed under
moderate conditions, as described (35). The densitometric count obtained with the dr1160 or hucR probe for each RNA sample was normalized by multiplying by the ratio of sample 32P-labeled groES counts
to control RNA 32P-labeled groES counts. RNA dot blot analysis was
performed in duplicate from separate RNA preparations. The levels of
hucR and dr1160 transcript from cells grown in 10 mM uric acid are
reported as the mean ⫾ S.D. relative to the transcript level from control
cells.
Analysis of Uricase Activity—D. radiodurans was grown in TGY or
TGY ⫹ 10 mM uric acid as described above. Cell pellets were resuspended in chilled HAP buffer, pH 7.5, without 2-mercaptoethanol and
lysed by sonication. Insoluble material was removed by centrifugation
at 4 °C. Protein concentrations of whole cell lysates were determined
from a BSA standard using the modified Lowry protein assay (Pierce).
Uricase activity in the whole cell lysate was analyzed using an
Amplex® Red Uric Acid/Uricase Assay Kit (Molecular Probes, Inc.,
Eugene, OR). Each reaction included 45 g of whole cell lysate protein.
Uricase activity is normalized to the activity recorded for cells grown in
the absence of added uric acid and is reported as the mean ⫾ S.D.
(n ⫽ 5).
RESULTS

The hucR Regulatory Region—Locus dr1159 in chromosome
I of D. radiodurans encodes a putative 181-residue, 19.7-kDa
MarR homolog. An intergenic region of 101 bp separates
dr1159 from the oppositely oriented ORF of a hypothetical
uricase (dr1160) (Fig. 1). Pairwise alignment of the predicted
protein product of dr1160 with a characterized uricase from
Bacillus subtilis indicates 29.5% identity and 54% similarity,

suggesting that the D. radiodurans homolog is functional (37).
Uricase catalyzes the conversion of uric acid into allantoin
during purine catabolism, and its activity is correlated with
oxidative stress response in mammals (38, 39). A downstream
locus, dr1161, encoding a hypothetical, transthyretin-like protein is oriented in the same direction as dr1160, with the ORFs
overlapping by one codon. A study of D. radiodurans promoter
elements indicated a strong similarity to the E. coli 70 consensus ⫺10 and ⫺35 regions among the promoters surveyed
(40). We identified 70-like promoter elements for dr1159 and
dr1160 in the sequence between these two genes. These promoter regions are partially overlapping, with the putative transcription initiation site of each gene positioned in the Pribnow
box of the other. The spacing and orientation of the hypothetical MarR homolog encoded at locus dr1159, relative to the
ORFs of dr1160 and dr1161, suggested a potential regulatory
design analogous to systems observed with other MarR proteins, such as MexR from P. aeruginosa and HpaR from E. coli
(8, 12). We were therefore prompted to designate dr1159 as
hucR (for hypothetical uricase regulator).
Sequence and Structural Analysis of HucR—Pairwise alignment of the amino acid sequence of HucR with the prototype of
this family, MarR, reveals 29% identity and 49% similarity
between these two proteins. Pairwise alignment with other
characterized MarR regulators shows that HucR shares higher
homology with EmrR and MexR, demonstrating 34% identity
with each and 55 and 49% similarity with these repressors,
respectively. Multiple sequence alignment of HucR with eight
representative MarR homologs reveals seven identical residues
in the C-terminal half of these proteins (Fig. 2). Five of these
sites (residues 118, 124, 126, 132, and 133) occur within the
␤-sheet and turn structural elements of MarR that form the
“wing 1” motif, and a sixth identical residue lies in an ␣-helix
immediately adjacent to this region (22, 41). The wing 1 structural element of the winged helix motif flanks the DNA recognition helix and has been shown to make direct contacts with
DNA, in either the minor or major groove (41). Of the 14
residues identified from the MarR crystal structure to form the
hydrophobic core of the monomeric DNA binding domain, 10
are conserved or identical in the MarR homologs analyzed (22).
Direct comparison of HucR and MarR reveals that five of these
residues are identical and an additional six are conserved.
The residues in the MarR monomer that were shown to make
contacts with the two salicylate ligands are highly conserved in
HucR. In ligand binding site “A” of MarR, Thr104 hydrogenbonds with the salicylate hydroxyl, Arg118 hydrogen-bonds
with the salicylate carboxylate, and Pro89 is located within 3.5
Å of the unsubstituted side of the salicylate ring. In HucR,
Arg118 and Pro89 are conserved, whereas serine replaces threonine at position 104. Arg109 in MarR, which is conserved in
HucR, hydrogen-bonds to the salicylate carboxylate group in
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FIG. 2. Multiple sequence alignment of HucR and representative MarR family members. The alignment was generated using ClustalX,
and conserved residues were colored using MacBoxshade. The numbering is based upon the HucR sequence. Residues that are identical in all nine
homologs are shaded red. Residues that are ⱖ80% conserved are shaded blue/green, where green indicates nonidentity to the HucR residue at that
position. Plus signs above the sequence designate residues identified from the MarR crystal structure to form the hydrophobic core of the
monomeric DNA binding domain (22). The helix-turn-helix DNA-binding motif and flanking ␤-sheet and “wing 1” region identified from the MarR
crystal structure are designated below the alignment. The numbering of the secondary structural elements is as reported for MarR, with ␣4 being
the DNA recognition helix. Proteins are HucR from D. radiodurans R1, a homolog from S. meliloti (NP_384406), two homologs from A. tumefaciens
(NP_530978 labeled as 1 and NP_353303 as 2), EmrR from E. coli (P24201), MexR from P. aeruginosa (C83593), PecS from E. chrysanthemi
(P42195), MarR from E. coli (P27245), and HpaR from E. coli (Q07095).

site “B” of MarR. Val128 of MarR is positioned 3.6 Å above the
salicylate ring in site “A” of the adjacent half of the dimer. This
valine is replaced by alanine in HucR.
The coding region of hucR was cloned into a pET5a expression vector, and the product, HucR, was purified to greater
than 95% homogeneity, as revealed by SDS-PAGE (Fig. 3). The
far-UV circular dichroism spectrum from 250 –190 nm was
recorded at 25 °C to determine the secondary structure composition of HucR (Fig. 4). The ␣-helical and ␤-sheet content for
HucR was calculated to be ⬃47 and 10%, respectively, with
17% turns and 25% random coil (28 –32). In comparison, the
crystal structure of MarR revealed its composition to be ⬃58%
helical and 10% ␤-sheet (22). The MexR crystal structure also
revealed a large ␣-helical content and a relatively small ␤-sheet
contribution (42). Ellipticity measurements at five wavelengths
spanning the negative ellipticity maximum characteristic of
␣-helices (220 –224 nm) were recorded over the temperature
range of 19 –70 °C and plotted to measure protein denaturation
(Fig. 4B). From the CD melting curve, the Tm of HucR was
calculated to be 51.1 ⫾ 0.0 °C. HucR did not refold during the
reverse temperature scan, so ⌬H0 values for folding transitions
could not be determined.
Binding of HucR to Its Promoter/Operator Region—Given the
prevalence of autoregulatory MarR transcription factors, we
biochemically assessed HucR for such a capacity. To test the
affinity of HucR for its promoter/operator region (hucO), we

FIG. 3. Purified HucR. HucR was purified to ⬎95% homogeneity.
Lane 1, molecular mass marker in kDa; lane 2, 1 g of purified HucR.
Monomeric HucR migrates at ⬃19 kDa, close to its predicted molecular
mass of 19.7 kDa.

amplified a 241-bp region of the D. radiodurans genome, extending from 180 bp upstream of the putative hucR translation
start site to 61 bp within the coding region. EMSA revealed
HucR to have high affinity for hucO, with an apparent Kd of
0.29 ⫾ 0.02 nM (Fig. 5) and a concomitant ⌬Gassoc of ⫺12.9
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FIG. 4. CD spectral analysis of HucR. A, far-UV CD spectrum of
HucR at 25 °C. Ellipticity measurements are expressed in machine
units (millidegrees). B, thermal unfolding transition of HucR. Ellipticity measurements were collected over the temperature range of 19 –
70 °C at five wavelengths spanning the negative ellipticity maximum
characteristic of ␣-helices: 220 nm (●), 221 nm (f), 222 nm (䡺), 223 nm
(Œ), and 224 nm ().

kcal/mol. The single complex observed and the goodness of fit to
a single-site binding polynomial suggested that HucR binds
hucO at a single site. The specificity of this interaction was
verified by the inability of pGEM5 to compete for HucR binding
(Fig. 5B). Complex formation between 1 nM HucR and 0.1 nM
32
P-labeled hucO was reduced to half-saturation at ⬃1 nM
unlabeled hucO, whereas only a minor reduction in complex
formation was elicited by 10 nM pGEM5. Since pGEM5 contributes an approximately 12-fold greater molar excess of base pairs
than hucO, the competition assay, in conjunction with footprinting analyses (see below), unequivocally demonstrates sitespecific binding of HucR and hucO. From EMSA performed under stoichiometric conditions, HucR was shown to bind hucO at a
ratio of 1.85:1, suggesting that HucR binds its promoter/operator
region as a dimer (Fig. 5D). This finding is consistent with crystallographic and biochemical analyses of other MarR homologs
which have also been shown to form homodimers (13, 22, 42).
Methidiumpropyl-EDTA-Fe(II) (MPE-Fe(II)) and DNase I
footprinting was performed using the top strand of a 77-bp
hucO fragment. MPE-Fe(II) footprinting revealed the HucR
dimer to protect 21 bp of hucO spanning the region from ⫺19 to
⫹3 relative to the putative uricase (dr1160) transcriptional
start site (Fig. 6). The footprint was extended by partial protection of bp ⫺20 and ⫺21. The footprint generated by DNase
I (Fig. 6) shows protection from ⫺18 to ⫹6, relative to the
uricase transcriptional start site. Analysis of the DNase I footprint also revealed sites of hypersensitive cleavage flanking
each end of the HucR dimer binding site (⫹8, ⫹7, and ⫺19),

suggesting that HucR distorts hucO upon binding. Winged
helix proteins from the MarR family characteristically bind as
dimers to inverted repeat sequences in their cognate recognition
sites (12). Footprinting analysis revealed the HucR dimer binding site within hucO to contain an imperfect 8-bp inverted repeat,
with 2 bp separating each half of the palindrome (Fig. 1).
Ligand Binding Assays—Members of the MarR family of
transcriptional regulators are natural phenolic sensors and
hence play critical roles in environmental surveillance. Given
the significant conservation in HucR of residues that are involved in binding salicylate in MarR, we tested this anionic
lipophilic compound as a potential ligand of HucR. Normalized
fractional HucR-hucO complex formation was analyzed as a
function of sodium salicylate concentration (Fig. 7). Sodium
salicylate antagonized the binding of HucR to hucO, with a 5.2
mM concentration of the compound reducing the normalized
fractional saturation to 0.5. At 25 mM sodium salicylate, the
fraction of complexed hucO approached zero. Since BSA is
known to bind salicylate, it was possible that, due to the BSA in
the binding reaction, the antagonistic effect of salicylate on
HucR-hucO interaction was greater than we observed. However, removal of BSA from the binding reactions resulted in no
observable change in the role of salicylate as a negative effector
of HucR (data not shown).
Acetylsalicylate was suggested to induce transcription of the
marRAB operon in vivo, yet in vitro analysis suggested that
acetylsalicylate does not bind MarR (16, 18). Acetylsalicylate
caused a gradual decrease in complexed hucO with increasing
drug concentration; however, even at 25 mM acetylsalicylate,
the normalized fractional saturation of hucO remained at ⬃0.6.
Approximately 46 mM acetylsalicylate is required to reduce the
fractional saturation to 0.5. Therefore, an acetyl group esterified to the 2-hydroxyl of salicylate decreases by 9-fold the
negative effector capacity of the ligand.
The apparent phenolic sensing capability of HucR and its
high affinity for a site within the promoter/operator region of a
putative uricase (Fig. 1) suggested a potential catabolic regulatory system in which HucR regulation of uricase expression is
responsive to levels of uric acid, the substrate for this enzyme.
Like salicylic acid, uric acid is a planar, aromatic compound but
consists of two conjugated ring systems. As seen in Fig. 7, uric
acid is a potent regulator of HucR; the normalized fraction of
complexed hucO approached zero at ⬃1 mM uric acid, with 0.26
mM uric acid being sufficient to reduce the normalized fractional complex to 50%. Uric acid is therefore an ⬃20-fold stronger antagonist of HucR-hucO interaction than salicylate and
over 175-fold stronger than acetylsalicylate. This pronounced
attenuation of complex formation elicited by uric acid, relative
to the effects observed from the other aromatic compounds,
suggests that this compound is the natural ligand of HucR.
In Vivo Analysis of Gene Regulation by HucR—The in vitro
investigations described above are consistent with a model in
which transcription of hucR and dr1160 (putative uricase) is
regulated by the high affinity interaction of HucR in the intergenic region. The dramatic reduction in HucR-hucO affinity
educed by uric acid suggests that this compound would weaken
HucR-mediated repression. Furthermore, the homology between the hypothetical enzyme encoded by dr1160, the only
putative uricase in the D. radiodurans genome, and the characterized uricase from B. subtilis suggests that this gene encodes a functional enzyme (37). We investigated this model
through a combination of RNA dot blot hybridization and
uricase activity experiments.
Transcript levels of hucR and dr1160 were compared from
D. radiodurans grown in the presence versus absence of 10 mM
uric acid (Fig. 8A). RNA dot blot hybridization of a 32P-labeled
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FIG. 5. HucR binding to its promoter/operator region, hucO. A, EMSA.
0.1 nM hucO was titrated with HucR. Uncomplexed hucO and the single hucOHucR complex are identified by arrows.
Protein concentrations are indicated
above the corresponding lanes. B, competition assay. 0.1 nM labeled hucO and 1 nM
HucR was titrated with up to a 10 nM
concentration of either unlabeled hucO or
pGEM5, and complexes were resolved by
EMSA. The first lane contains only labeled hucO. Concentrations of unlabeled
competitor DNA are indicated above the
corresponding lanes. Complexed and uncomplexed hucO are identified by arrows.
C, binding isotherm depicting normalized
hucO fractional saturation as a function
of uncomplexed HucR. Data were collected in triplicate. D, stoichiometry of
HucR-hucO complex formation.

probe complementary to the sense strand of hucR revealed a
higher level of transcript in cells grown in 10 mM uric acid, at
a ratio of 1.6 ⫾ 0.1 relative to control cells. Hybridization of a
probe complementary to the sense strand of dr1160 revealed
up-regulation of the putative uricase in the cells grown in 10
mM uric acid, at a ratio of 1.6 ⫾ 0.0 relative to control cells.
A coupled enzymatic assay was performed to assess uricase
activity in protein from whole cell lysate of cells grown in the
presence versus absence of 10 mM uric acid (Fig. 8B). The assay
links the activity of uricase from the samples to the activity of
horseradish peroxidase, producing resorufin, which has an absorption maximum near 560 nm. Uricase activity was detected
in cells supplemented with or without uric acid, suggesting

that dr1160 does indeed encode a functional uricase. Uricase
activity was 1.5 ⫾ 0.0 times higher in cells grown in the
presence of 10 mM uric acid compared with its absence. The
enhanced levels of hucR and dr1160 transcript and the elevated uricase activity in cells grown in excess uric acid are
consistent with the in vitro ligand binding studies with HucR
and strongly support a model in which transcription of these
two divergent genes is derepressed by the effector uric acid.
DISCUSSION

The identification of MarR homologs within the D. radiodurans genome suggested the presence of uncharacterized regulatory systems responsive to phenolic compounds within this

51448

HucR, a Novel Uric Acid-responsive MarR Homolog

FIG. 6. Footprinting analysis of
HucR-hucO complex. A, DNase I (lanes
1–3) and MPE-Fe(II) (lanes 4 –9) footprinting of the top strand of hucO. Lanes
1 and 4, A/G ladder; lane 2, DNase I treatment of hucO in the absence of HucR; lane
3, DNase I treatment of hucO incubated
with 200 nM HucR. Lanes 5–9, MPEFe(II) treatment of hucO after incubation
with 0, 25, 100, 200, or 400 nM HucR,
respectively. The predicted positions of
the dr1160 ⫺10 promoter element and
transcriptional start site are indicated at
the right. B, densitometric profile of the
HucR-hucO complex, as determined by
MPE-Fe(II) footprinting. MPE-Fe(II)treated hucO in the absence of HucR is
represented by the gray trace. The dark
line represents DNA incubated with 200
nM HucR (lane 8 in A). C, densitometric
profile of the HucR-hucO complex, as determined by DNase I footprinting. The
gray line shows the densitometric trace of
DNase I-treated hucO in the absence of
HucR. DNase I cleavage of hucO incubated with 200 nM HucR is represented by
the dark trace. Sequence numbering in
A–C is relative to the predicted ⫹1 transcriptional start site of dr1160, as in
Fig. 1.

stress-resistant microorganism. In this study, we demonstrate
that HucR binds with very high affinity (Kd ⫽ 0.29 ⫾ 0.02 nM)
at a single site in its regulatory region (Figs. 5 and 6). In
comparison, E. coli MarR binds its cognate site with an apparent Kd of 1 nM, and the winged helix protein, Ptr1, binds its
cognate sites with apparent Kd values of 1–2 nM (18, 43).
Winged helix proteins from the MarR family characteristically
bind to sites containing palindromic or pseudopalindromic sequences. HpaR, for example, binds to sequences possessing two
9-bp half-sites separated by 2 bp, and CinR binds to a 16-bp
palindrome composed of two adjacent 8-bp half-sites (8, 14).
The binding site of EmrR contains an imperfect 9-bp inverted
repeat with each half-site separated by 3 bp (10). The binding
site for HucR contains an imperfect 8-bp inverted repeat, with
each half-site separated by 2 bp (Figs. 1 and 6). The center of
each half-site of the palindrome is therefore separated by 10 bp,
thus positioning the binding site for each half of the HucR

homodimer on the same face of the double helix. This contrasts
with the binding site of MarR, which contains two inverted
5-bp sequences separated by 2 bp, thus positioning the halfsites on different faces of the double helix (18). In the case of
MexR, the 5-bp inverted repeat sequences are separated by 5
bp, which would orient the major groove of each half-site on the
same face of the DNA helix (12). There is variation within
the winged helix family in the mode of DNA binding, but the
recognition helix typically makes most of the sequence-specific
contacts within the major groove (38, 44). It is therefore likely
that HucR shares a similar mode of DNA binding with its two
closest characterized homologs, EmrR and MexR, in which the
recognition helix of each half of the homodimer binds in the
major groove on the same face of the double helix.
A number of autoregulatory members of the MarR family
have been described, including repressors that, like HucR, are
not encoded in a contiguous operon. The position of the HucR
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FIG. 7. HucR effector binding assays. A, structures of the compounds tested: salicylic acid, acetylsalicylic acid, and uric acid (shown in
its more stable keto tautomeric conformation). B, EMSA demonstrating
the capacity of uric acid as a negative effector of HucR binding to its
cognate DNA-binding site. Uric acid concentrations (in mM) are shown
above the corresponding lanes. Bands corresponding to free hucO and
hucO-HucR complex are marked by arrows. Lane 1, hucO incubated
with 15 mM uric acid in the absence of HucR. C, normalized hucO-HucR
complex formation as a function of ligand concentration. Experiments
were performed in triplicate. Œ, sodium salicylate; f, acetylsalicylate;
〫, uric acid.

binding site in hucO suggests a mechanism of simultaneous
transcriptional repression of the divergent hucR and uricase
genes, involving steric inhibition of RNA polymerase recruitment to the promoter or elongation. The orientation of hucR
and the uricase gene, with an intervening regulatory region, is
similar to the genetic organization of other MarR homologs. For
example, MexR binds to two sites in the mexR-mexA intergenic
region, with each binding site containing promoter elements of
each gene, explaining the mechanism of MexR repression (12).
HpaR regulates its own expression and that of an oppositely
oriented gene cluster by binding in the central operator/promoter region (8).
Our finding that salicylate is a negative effector of HucRhucO interaction is consistent with HucR conservation of residues that form the salicylate binding site in MarR (Fig. 7) (22).
The decreased affinity of HucR (and MarR) for acetylsalicylate
is probably due to the extra acetyl group and the concomitant
loss of hydrogen bonding capacity with Ser104 (Thr104 in MarR)
(18). An explanation of the apparent higher affinity of HucR for
uric acid compared with salicylate awaits structural details of
this protein. The efficient antagonism of HucR-hucO interaction by uric acid suggests a regulatory mechanism of uric acid
catabolism (Fig. 7). Several repressors of aromatic catabolic
pathways from the MarR family have been characterized (45).
For instance, HpaR represses the transcription of genes involved in the catabolism of 4-hydroxyphenylacetic acid, and
this repression is relieved by the binding of the substrate,
4-hydroxyphenylacetic acid, to HpaR (8). The repression of a
cinnamoyl ester hydrolase by CinR is relieved by aromatic
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FIG. 8. Analysis of hucR and dr1160 (uricase) gene expression.
A, expression of hucR and dr1160 in log phase cells grown in the
absence (black bars) or presence (cross-hatched bars) of 10 mM uric acid,
as determined by RNA dot blot analysis. Transcript levels of hucR and
dr1160 were calculated using radiolabeled probes complementary to the
sense strand of the respective gene, as indicated on the x axis. The
transcript levels of uric acid-supplemented cells are reported relative to
those of control cells. The error bars indicate the S.D. values from two
experiments. B, analysis of uricase activity in log phase cells grown in
the absence (black bars) or presence (cross-hatched bars) of 10 mM uric
acid. Uricase activity is measured by the absorbance of resorufin at 560
nm. Activity in uric acid-supplemented cells is reported relative to that
in control cells. The error bar indicates the S.D. value from five
experiments.

substrates of this enzyme (14). The catabolism of uric acid in
D. radiodurans is probably regulated in an analogous manner,
with uric acid directly relieving HucR-mediated repression of
uricase levels in the cell. This model of co-repression of hucR
and dr1160 (predicted uricase) is supported by RNA dot blot
analysis, which reveals uric acid-induced up-regulation of both
genes to similar transcript levels in D. radiodurans (Fig. 8A)
and by the up-regulation of uricase activity in the presence of
excess uric acid (Fig. 8B). Since dr1160 is the only uricase
homolog in the D. radiodurans genome, we interpret these
results as support of a model of HucR-mediated regulation.
The physiological significance of uricase regulation in
D. radiodurans is unclear. This enzyme acts as part of the
purine degradation pathway in prokaryotes and in eukaryotes.
In primates, birds, terrestrial reptiles, and many insects, uric
acid is the final product of purine catabolism and is excreted
into the environment. Selected soil bacteria are capable of
catabolizing uric acid as a carbon and energy source, including
strains of Bacillus fastidiosus, which require uric acid (or its
degradation products allantoin and allantoic acid) as a substrate for growth (46). B. subtilis can utilize uric acid as its sole
nitrogen source (47). Since D. radiodurans is also a soil-dwelling microorganism, it is tempting to speculate on the possibility
that it, too, has acquired the capacity to use uric acid as a
source of carbon, energy, or nitrogen.
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Analysis of 16 S ribosomal DNA sequences suggests that
Deinococcus forms a separate bacterial phylum with the thermophilic Thermus genus (48). However, the Tm of 51.1 ⫾ 0.0 °C
for HucR, is similar to the Tm values (at similar salt concentrations) of other helix-turn-helix transcriptional regulators
from mesophilic organisms, such as the LacI DNA-binding
domain, which has a Tm of 45.6 ⫾ 0.2 °C, and the DNA-binding
domain of MAT␣2, which has a Tm of 56.5 °C (49, 50). Despite
the close relationship of Deinococcus to a thermophilic genus,
HucR does not appear to be an unusually thermostable protein.
HucR shares the highest sequence similarity to uncharacterized MarR homologs from Sinorhizobium meliloti and Agrobacterium tumefaciens (Fig. 2), both of which are soil-dwelling,
mesophilic, plant symbionts from the family Rhizobiaceae. This
family is grouped with the Proteobacteria, a eubacterial lineage
that is distantly related to Deinococcus. Pairwise alignment of
HucR and its homolog from Sinorhizobium shows 38% sequence identity and 55% similarity. Alignment with each of the
Agrobacterium homologs reveals 36.5% identity and 55.7% similarity. Since D. radiodurans is a soil-dwelling mesophile, it is
plausible that the similarity of HucR to these rhizobial proteins
is a result of horizontal gene transfer (25). Multiple genes in
D. radiodurans appear to have been acquired via horizontal
transfer, including at least seven stress response genes that
were probably acquired from species belonging to the family
Rhizobiaceae (25). The potential role of HucR in regulating uric
acid levels suggests that it too is involved in D. radiodurans
stress response. Uric acid is an efficient scavenger of reactive
oxygen species, including hydroxyl radicals, superoxide anion,
and singlet oxygen, and is thought to be a critical antioxidant
in mammals (51, 52). Indeed, D. radiodurans demonstrates
extreme resistance to oxidative damage (53–55). HucR-mediated regulation of uric acid levels in D. radiodurans could
therefore contribute to this organism’s observed resistance to
high levels of oxidative stress. It has been demonstrated that
oxygen increases the lethality of ionizing radiation in D. radiodurans presumably by generating reactive oxygen species (56).
By regulating levels of uric acid, HucR could therefore also
participate in the response of D. radiodurans to ionizing radiation. It is likely that the sensitivity of HucR activity to levels
of uric acid serves to maintain an optimum level of this scavenger of peroxynitrite and other reactive oxygen species in the
cytoplasm. The low solubility of uric acid is well documented
and is manifested in precipitate-related health problems such
as gout in humans. Other proteins in this family have been
shown to regulate resistance to oxidative stress, including
MarR, SlyA, and OhrR (57–59). PecS control of indigoidine, an
apparent radical scavenger, regulates E. chrysanthemi resistance to reactive oxygen species (7). It is thus tempting to
speculate that HucR shares with these MarR homologs a common functional role of mediating oxidative stress response.
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